RN7SL619P

Across TCGA pan-cancer cohorts, RN7SL619P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL619P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL619P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL619P is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

COAD, READ, and CHOL are the cancer types where RN7SL619P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL619P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.458	<.001	7	view →
READ	Female	All	+0.772	.009	2	view →
CHOL	All	All	+0.410	.027	2	view →
STAD	All	All	+0.319	.020	2	view →
KIRC	All	II,III,IV	−0.070	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL619P–COAD

Open the COAD breakdown →